Tag Archives: Blood pressure

Feds Threaten to Pull ProAmatine for Lack of Postmarket Data (Updated 8/18)

By George Koroneos | Published: August 16, 2010

Image via Wikipedia FDA on Monday announced that it was looking to withdraw approval for the low-blood-pressure treatment midodrine hydrochloride because the companies manufacturing the drug failed to provide data from post-approval studies. The kicker: The drug was approved 14 years ago. FDA gave midodrine hydrochloride—branded by Shire as ProAmatine and produced by a half-dozen generics firms—the green [...]

Posted in FDA | Also tagged Center for Drug Evaluation and Research, Clinical trial, Drug, Food and Drug Administration, Health, Midodrine, pharmaceutical industry, Shire | 1 Comment

Strategic Patient Adherence Awards: “And the Winners Are”

By George Koroneos | Published: May 6, 2009

Pharm Exec was proud to partner this year with CBI on the eighth annual Forum on Patient Compliance, Adherence & Persistency. One of the highlights of the event is the presentation of the Strategic Patient Adherence Awards, which honor pharma-based programs to improve compliance. The winners this year: For best branded program AstraZeneca Canada for a program [...]

Posted in Events | Also tagged Anastrozole, Breast cancer, Chronic obstructive pulmonary disease, Conditions and Diseases, Feedback, Health, hypertension | Leave a comment